期刊文献+

粪便钙卫蛋白与炎症性肠病活动性关系的探讨 被引量:5

A Study of Relationship between Fecal Lactoferrin and Inflammatory Bowl Disease
下载PDF
导出
摘要 探讨研究粪便钙卫蛋白与炎症性肠病(inflammatory bowl disease,IBD)活动性的关系。收集52例北京军区总医院消化内镜中心接受肠镜检查患者的新鲜粪便标本提取钙卫蛋白,其中炎症性肠病患者32例、溃疡性结肠炎24例、克罗恩病8例、正常对照者20例。采用ELISA法定量检测粪便中钙卫蛋白浓度。采用Mayo评分系统判断IBD有否活动,积分≥3为有活动性。结果20例健康者粪便钙卫蛋白浓度为(77.15±160.9)μg/g,32例IBD患者为(646.58±439.44)μg/g。IBD患者与健康者粪便钙卫蛋白浓度比较有显著差别(P<0·001)。以450·3μg/g为临界值时,粪便钙卫蛋白判断IBD是否活动的灵敏度和特异度分别为75%和90%,活动期IBD患者与静止期IBD患者和健康者粪便钙卫蛋白浓度比较均有显著差别(P<0.05)。说明粪便钙卫蛋白检测是一种非侵入性观察指标,为判断IBD活动性具有一定的临床意义。 To investigate the relationship between levels of fecal calprotection in the inflammatory bowl disease (IBD) of activated and inactivated by ELISA quantitative analysis, a total of 52 fresh fecal samples were collected from the patients with IBD and the healthy volunteers, including 24 cases of UC, 8 cases of CD, and 20 healthy volunteers. EK-CAL was used to quantitatively determine the level of fecal calprotection. Mayo active index adoptied to evaluate the activity of IBD. The score equal or higher than 3 considered to be active IBD. The level of fecal calprotection was (77.15 ± 160.9) μg/g in healthy volunteers, (956.13 ±488.36) μg/g in active IBD, (337.06 ± 390.52)μg/g in inactive IBD, respeetively. There was signifieanted differenee between the IBD compared with the healthy volunteers (P 〈 0. 001 ). When IBD beeame active, the level of feeal ealprotection increased significantly compared with the inaetive IBD and healthy volunteers, respectively ( P 〈 0. 05 ). When the upper limit was 450. 3 μg,/g,the sensitivity and specificity of fecal ealproteetion in differentiating the active IBD was 75% and 90%, respectively. As a non-invasive method, fecal ealproteetion is the marker for evaluate IBD activity, it has a clinical significance.
出处 《科学技术与工程》 2010年第8期1955-1958,共4页 Science Technology and Engineering
关键词 炎症性肠病(IBD) 钙卫蛋白 粪便 inflammatory bowl disease calprotection feces
  • 相关文献

参考文献11

  • 1中国炎症性肠病诊断治疗规范的共识意见[J].中华内科杂志,2008,47(1):73-79. 被引量:383
  • 2Gionchetti,D 'Arienzo A, Rizzello F, et al. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randominzed controlled trial. J Clinical Gastroenterology, 2005; 39 (4): 291-297. 被引量:1
  • 3陈卫中,潘晓平,宋兴勃,倪宗瓒.ROC曲线中最佳工作点的选择[J].中国卫生统计,2006,23(2):157-158. 被引量:95
  • 4Johne B, Fagerhol M K, Lybrg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. J Clin Path-Mol Path, 1997; 50 (3) : 113-123. 被引量:1
  • 5Gebhardt C, Nemeth J, Angel P,et al. S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology, 2006 ; 72 ( 11 ) : 1622-1631. 被引量:1
  • 6Roseth A G, Schmldt P N, Fagerhol M K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroentero, 1999; 34(1) : 50-54. 被引量:1
  • 7Sander J, Fagerlol M K, Bakkon J S, et al. Plasma levels of the leukocyte L1 protein in febrile conditions: relation to aetilolgy, number of leucocytes in blood, blood sedimentation reaction and C-reaction protein. Scand J Clin Lay Invest, 1984; 44 (4) : 357-362. 被引量:1
  • 8Roseth A G, Fagerhol M K, Aadland E. Assessment of the neutrophil dominating protein calprotectin in feces, a methodogic study. Stand J Gastroenterol, 1992 ; 27 (9) :793-798. 被引量:1
  • 9IncUr R D, Pont E D, Leo V D, et al. Calprotectin and lactoferrin in the assessmen of intestinal inflammation and organic disease. Int J Colorectal Dis, 2007 ; 22 (4) : 429-437. 被引量:1
  • 10Schoepfer A M, Trummler M, Seeholzer P, et al. Accuracy of four fecal assays in the diagnosis of colitis. Dis Colon Rectum, 2007 ; 50 (10) : 1697-1706. 被引量:1

二级参考文献30

  • 1刘杰,林一帆,张沥,胡家露,曹晓燕,樊代明.图象自动分析检测MG7抗原表达预测胃癌高危价值探讨[J].中华预防医学杂志,1996,30(5):286-288. 被引量:13
  • 2宇传华 徐勇勇.ROC分析的基本原理[J].中华流行病学杂志,1998,19(2):413-415. 被引量:17
  • 3潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 4潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 5Hanley JA,McNeil BJ.The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology,1982:29-36. 被引量:1
  • 6England WL.An exponential model used for optimal threshold selection on ROC curves.Medical Decision Making,1988(8):120-131. 被引量:1
  • 7Robert JG et al,Determination and interpretation of the Optimal Opersting Point for ROC Curves derived through generalized linear models.Understanding Statistics,2003,2(4):219-242. 被引量:1
  • 8Riddle D L,Stratford PW.Interpreting validity indexed for diagnostic tests:An illustration using Berg Balance Test.Physical Therapy,1999,79:939-948. 被引量:1
  • 9Feinstein AR.Clinical epidemiology:architecture of clinical research.WB Saunders Company,1985:601-632. 被引量:1
  • 10Peng MS,So TSH.logistic regression analysis and reporting:A primer.Understanding Statistics,2002,1:31-70. 被引量:1

共引文献475

同被引文献37

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部